Real-World Effectiveness of Lebrikizumab in Patients With Head-Neck Atopic Dermatitis: A Multicenter Study With Focus on Flare Occurrence. (PubMed, Int J Dermatol) - Sep 26, 2026 - "Lebrikizumab demonstrated rapid and sustained effectiveness in patients with HND, with marked improvements in disease severity, pruritus, and quality of life. Head-neck flares were relatively uncommon and generally manageable with topical therapies."
Clinical • Journal • Real-world evidence • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Pruritus
|
|
Alessandra Narcisi; Cataldo Patruno; Francesca Barei; Francesca di Vico; Luca Potestio; Luciano Ibba; Luigi Gargiulo; Maddalena Napolitano; Marianna Cimmino; Marika Del Gaudio; Martina Turco; Martina Zussino; Matteo Bianco; Paolo Calzari; Ruggero Cascio Ingurgio; Silvia Mariel Ferrucci
|